Fortress Biotech (NASDAQ:FBIO – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 27th.Analysts expect the company to announce ...
Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for ...
Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback